Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

3518 ARTÍCULOS , VIENDO DEL 3121 AL 3135

Serum fatty acid profiles using GC-MS and multivariate statistical analysis: potential biomarkers of Alzheimer's disease

Wang DC, Sun CH, Liu LY, Sun XH, Jin XW, Song WL, Liu XQ, Wan XL.

Neurobiol Aging. 2012 Jun;33(6):1057-66. doi: 10.1016/j.neurobiolaging.2010.09.013. Epub 2010 Oct 27.

Epigenetic modification is linked to Alzheimer's disease: is it a maker or a marker?

Lee J, Ryu H.

BMB Rep. 2010 Oct;43(10):649-55. doi: 10.5483/BMBRep.2010.43.10.649.

YKL-40: a novel prognostic fluid biomarker for preclinical Alzheimer's disease

Craig-Schapiro R, Perrin RJ, Roe CM, Xiong C, Carter D, Cairns NJ, Mintun MA, Peskind ER, Li G, Galasko DR, Clark CM, Quinn JF, D'Angelo G, Malone JP, Townsend RR, Morris JC, Fagan AM, Holtzman DM.

Biol Psychiatry. 2010 Nov 15;68(10):903-12. doi: 10.1016/j.biopsych.2010.08.025.

Deletion of CD14 attenuates Alzheimer's disease pathology by influencing the brain's inflammatory milieu

Reed-Geaghan EG, Reed QW, Cramer PE, Landreth GE.

J Neurosci. 2010 Nov 17;30(46):15369-73. doi: 10.1523/JNEUROSCI.2637-10.2010.

Transforming growth factor beta and soluble endoglin in the healthy senior and in Alzheimer's disease patients

Juraskova B, Andrys C, Holmerova I, Solichova D, Hrnciarikova D, Vankova H, Vasatko T, Krejsek J.

J Nutr Health Aging. 2010 Nov;14(9):758-61. doi: 10.1007/s12603-010-0325-1.

Regions of homozygosity and their impact on complex diseases and traits

Ku CS, Naidoo N, Teo SM, Pawitan Y.

Hum Genet. 2011 Jan;129(1):1-15. doi: 10.1007/s00439-010-0920-6. Epub 2010 Nov 23.

Biomarkers for Alzheimer's disease therapeutic trials

Hampel H, Wilcock G, Andrieu S, Aisen P, Blennow K, Broich K, Carrillo M, Fox NC, Frisoni GB, Isaac M, Lovestone S, Nordberg A, Prvulovic D, Sampaio C, Scheltens P, Weiner M, Winblad B, Coley N, Vellas B; Oxford Task Force Group.

Prog Neurobiol. 2011 Dec;95(4):579-93. doi: 10.1016/j.pneurobio.2010.11.005. Epub 2010 Dec 2.

Do extracellular chaperone proteins in plasma have potential as Alzheimer's disease biomarkers?

Thambisetty M.

Biomark Med. 2010 Dec;4(6):831-4. doi: 10.2217/bmm.10.108.

Recent cerebrospinal fluid biomarker studies of Alzheimer's disease

Choi YS, Choe LH, Lee KH.

Expert Rev Proteomics. 2010 Dec;7(6):919-29. doi: 10.1586/epr.10.75.

Diagnosis and biomarkers of predementia in Alzheimer's disease

Forlenza OV, Diniz BS, Gattaz WF.

BMC Med. 2010 Dec 22;8:89. doi: 10.1186/1741-7015-8-89.

Letter from the Editor: stratified medicine

Reichert JM.

MAbs. 2010 Mar-Apr;2(2):107. doi: 10.4161/mabs.2.2.11320.

Urine neural thread protein measurements in Alzheimer disease

Youn YC, Park KW, Han SH, Kim S.

J Am Med Dir Assoc. 2011 Jun;12(5):372-6. doi: 10.1016/j.jamda.2010.03.004. Epub 2010 Oct 2.

Disclosure of elevated amyloid status is not associated with long-term suicidality in a preclinical AD trial

Grill JD, Raman R, Flournoy C, Ernstrom K, Pierce A, Smith A, Rosenberg P, Burns J, Karlawish J, Aisen P, Holdridge KC, Mancini M, Sperling R, Sultzer D; A4 Study Team.

Alzheimers Dement. 2025 Feb;21(2):e14623. doi: 10.1002/alz.14623.

Short communication: Evaluating roles of plasma glial fibrillary acidic protein as Alzheimer's disease biomarker in real-world multi-center memory clinics in Thailand

Taweephol T, Pongpitakmetha T, Booncharoen K, Khieukhajee J, Luechaipanit W, Haethaisong T, Chongsuksantikul A, Likitjaroen Y, Thanapornsangsuth P.

J Alzheimers Dis. 2025 Mar;104(2):325-330. doi: 10.1177/13872877251316546. Epub 2025 Feb 9.

[A case of neuronal intranuclear inclusion disease with coexisting Alzheimer's disease biomarker signature in cerebrospinal fluid]

Ono N, Maruyama G, Akaiwa Y, Nakamura T, Tamai C, Sone J, Miyamoto T.

Rinsho Shinkeigaku. 2025 Dec 19;65(12):912-915. doi: 10.5692/clinicalneurol.cn-002153. Epub 2025 Nov 22.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias